Last Updated: August 2, 2026

MESNA Drug Patent Profile

✉ Email this page to a colleague

When do Mesna patents expire, and what generic alternatives are available?

Mesna is a drug marketed by Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Mylan Institutional, Rising, Sagent Pharms Inc, Teva Pharms Usa, and Ingenus Pharms Llc. and is included in nine NDAs.

The generic ingredient in MESNA is mesna. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the mesna profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Mesna

A generic version of MESNA was approved as mesna by FRESENIUS KABI USA on April 26^th, 2001.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for MESNA?
What are the global sales for MESNA?
What is Average Wholesale Price for MESNA?

Summary for MESNA

US Patents:	0
Applicants:	9
NDAs:	9

US Patents and Regulatory Information for MESNA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eugia Pharma	MESNA	mesna	INJECTABLE;INTRAVENOUS	220518-001	Jan 27, 2026	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	MESNA	mesna	INJECTABLE;INTRAVENOUS	090913-001	Apr 13, 2010	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma	MESNA	mesna	INJECTABLE;INTRAVENOUS	075739-001	Jan 9, 2004	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.